• DOI:10.2165/00002018-200427130-00003
Corpus ID: 1773936

Safety of a New Oral Contraceptive Containing Drospirenone

@article{Heinemann2004SafetyOA,
  title={Safety of a New Oral Contraceptive Containing Drospirenone},
  author={L. Heinemann and J. Dinger},
  journal={Drug Safety},
  year={2004},
  volume={27},
  pages={1001-1018}
}

• L. Heinemann, J. Dinger
• Published 2004
• Medicine
• Drug Safety

New chemical entities must undergo rigorous, and preferably independent, safety and efficacy assessments before entry into the market. This is also true for oral contraceptives (OCs) given their extensive usage by healthy women and the safety concerns highlighted by the so-called ‘third generation pill scare’ in Europe a decade ago. This scare heightened patient and physician awareness of the increased risk of thromboembolic complications (mainly venous thromboembolism [VTE]) associated with OC… Expand